Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Technology advances, malaria-fighting efforts increase, and accurate and rapid diagnosis to treat diverse ailments are changing malaria diagnostics. Malaria RDTs are rising. Malaria may be detected quickly utilizing blood antigens in RDTs. This is consistent with worldwide malaria control objectives that aim to improve diagnosis, especially in resource-constrained locations with inadequate laboratory facilities.
Modern diagnostic technologies and their development are driving malaria diagnostics market growth. Nucleic acid amplification assays like polymerase chain reaction (PCR) are popular due to their great sensitivity and capacity to identify low-level infections. In malaria-endemic areas where asymptomatic infections are hard to detect, these emerging molecular diagnostic tools aid malaria diagnosis.
Malaria detection with digital technologies is growing. Digital platforms including mobile health (mHealth) apps and cloud-based solutions increase malaria data collecting, reporting, and monitoring. This trend meets the requirement for real-time data monitoring and makes malaria case tracking more efficient, improving public health interventions.
The malaria diagnostics industry is growing because to multiplexed tests. Multiplex testing can detect several malaria parasites and distinguish them from other febrile diseases. In areas with multiple malaria species, this accomplishment is significant. It lets doctors personalize malaria treatments to the organism that causes it.
Growing focus on point-of-care testing drives malaria diagnostics industry trends. Point-of-care diagnostics allow doctors to identify and treat patients quickly due to its speed and decentralization. This trend is especially strong in rural places with limited access to centralized labs. These places need timely identification to avert serious consequences and malaria transmission.
Due to the COVID-19 pandemic, malaria diagnostics emergencies have increased, highlighting the necessity for trustworthy diagnostic procedures in infectious disease management. The pandemic has shown the need of a strong diagnostic infrastructure for health emergencies. This tendency has led to increased expenditures in diagnostic capabilities, particularly malaria detection, to improve preparation and response to infectious threats.
Quality assurance and proficiency testing programs drive malaria diagnostics market expansion. Effective malaria prevention requires accurate and reliable diagnostic tests. Continuous efforts to establish and implement quality assurance standards, proficiency testing, and external quality evaluation programs increase malaria test diagnosis accuracy and confidence.
Clinical diagnostic corporations, research institutes, and public health authorities are collaborating to innovate malaria diagnoses. The combined initiatives aim to improve monitoring and reporting systems, increase diagnostic access in disease-endemic areas, and develop and test innovative diagnostic technologies. This movement promotes a global malaria eradication and diagnostics approach.
Fighting antimalarial medicine resistance is affecting malaria diagnostic breakthroughs. Diagnostic techniques help determine treatment choices and determine the incidence of resistant strains while monitoring drug resistance. Because of this tendency, constant monitoring with reliable diagnostic methods is more necessary than ever to guide evidence-based activities and ensure antimalarial treatment effectiveness.
Malaria diagnosis is advancing due to public-private collaborations and donor groups. Donor, NGO, and charity groups work with diagnostic firms to provide tests, educate staff, and support research and development. This trend improves healthcare infrastructure and availability to malaria-treating diagnostic technologies in malaria-endemic areas.
Malaria Diagnostics Market Highlights:
Global Malaria Diagnostics Market Overview
The Malaria Diagnostics Market Size valued at USD 0.045 Billion in 2023. The Malaria Diagnostics industry is projected to rise from USD 0.047 Billion in 2024 to USD 0.082 Billion by 2032, exhibiting a compound yearly growth rate (CAGR) of 6.23% during the forecast period (2024 - 2032).
Malaria is a parasitic disease conveyed by the bite of infected anopheles mosquitoes. The Plasmodium parasite is transmitted by infected mosquitos. The parasite is released into the circulation after being bitten by an infected mosquito. When the human body becomes the parasite's host, the parasite grows in the liver. The adult parasite enters the bloodstream and infects red blood cells after a few days. Fever, vomiting, weakness, and headache are common symptoms of malaria in humans. In recent years, the global market for malaria diagnostics has grown dramatically.
Malaria Diagnostics Market Trends
The market's expansion is mostly due to developments in technological innovations in diagnostic instruments, as well as rising demand for treatment in malaria-endemic nations. Furthermore, factors such as increased collaboration between research institutes and industry, as well as government funding, are expected to support market expansion in the estimated timeframe. Factors such as a lack of solid import-export rules, lack of knowledge, a weak regulatory framework, and a lack of suitable monitoring standards at the country level, on the other hand, are expected to limit the market's growth in the next years.
Malaria Diagnostics Market Segment Insights
The market of malaria diagnostics has been segmented on the basis of technology and end-user.
Malaria Diagnostics Technology Insights
On the basis of technology, the market has been classified as rapid diagnostic tests, microscopy, and molecular diagnostic tests. The molecular diagnostics tests are segmented into polymerase chain reaction (PCR) and real-time polymerase chain reaction (RT-PCR).
Malaria Diagnostics End-users Insights
On the basis of end-users, the market has been classified as hospitals, clinics, community healthcare, and others.
Malaria Diagnostics Regional Insights
On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas has been further segmented into North America and South America, with the North American market divided into the US and Canada.
The European market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The malaria diagnostics market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The malaria diagnostics market in the Middle East and Africa has been segmented into the Middle East and Africa.
In the global market, North America is anticipated to account for the largest market share due to the early adoption of advanced medical technologies, the rise in awareness, the rise in growth of the healthcare sector, and due to favorable compensation setting for many surgical procedures. In 2016, global governments of malaria-endemic countries have invested USD 2.7 billion in malaria control and elimination efforts. The US was the largest contributor by providing USD 1 billion for the eradication of malaria.
The European market is expected to hold the least share due to the growing number of malaria-free countries in the region.
The market share in Asia-Pacific is also projected to experience growth in the near future due to access to optimal treatment facilities and growing demand for advanced technology, better adoption rate, increase in disposable income, and rising medical tourism. The Asia-Pacific remains to be the second largest burden of malaria globally with 22 malaria-endemic countries accounting for roughly 28 million cases and 45,000 deaths every year. The WHO figures say that in the Asia-Pacific region, Myanmar, Pakistan, India, and Indonesia carry the highest malaria burden accounting for 89% of all malaria cases in the region.
The market in the Middle East and Africa is expected to account for the smallest share of the global malaria diagnostics market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities. Sub-Saharan Africa remains to bring an excessively high share of the global malaria burden on the Middle Eastern and African market. the region was home to 90% of malaria incidences and 92% of malaria deaths in 2015
Malaria Diagnostics Market Key Players
Some of the key players in the global market are
- Access Bio. Inc.
- Abbott Laboratories
- Premier Medical Corporation Pvt. Ltd
- Sysmex Partec GmbH
- bioMérieux
- Beckman Coulter Inc.
- Siemens Healthineers
- Leica Microsystems GmbH
- Nikon Corporation
- Olympus Corporation
- Bio-Rad Laboratories Inc
Recent Development
In March 2022, Audere, a digital health foundation dedicated to improving global health, announced a partnership with Medical Diagnostech, a designer and manufacturer of lateral flow fast diagnostic test kits. Medical Diagnostech's MD SARS-nCoV-2 Antigen Device1 will be paired with Audere's HealthPulsedigital companion app as part of the agreement. In February 2022, Kemri released the first domestically produced malaria and Covid-19 test kits. Both were freed by Health CAS Rashid Aman. Researchers of the Kenya Medical Research Institute created them. According to Aman, they have performed between three and four million Covid-19 tests thus far, and they are expensive. The ministry will assist the company with manufacturing and will be the product's primary consumer.
Malaria Diagnostics Market Segmentation
Malaria Diagnostics Technique Outlook
- Rapid diagnostic tests
- Microscopy
- Molecular diagnostic tests
- Polymerase chain reaction (PCR)
- Real-time polymerase chain reaction (RT-PCR)
Malaria Diagnostics End-Users Outlook
- Hospitals
- Clinics
- Community healthcare
- Others
Malaria Diagnostics Regional Outlook
Americas
- North America
- US
- Canada
- South America
Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Middle East & Africa
- Middle East
- Africa
Intended Audience
- Governmental Agency
- Educational Organizations
- Medical Device Manufacturers
- Research Institutes and Academic Centers
- Market Research and Consulting
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
